{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T12:48:15Z","timestamp":1782478095343,"version":"3.54.5"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006416","name":"Universidade Estadual De Campinas","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006416","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction and Hypothesis<\/jats:title>\n                    <jats:p>Intravesical injection of platelet-rich plasma (PRP) has emerged as a novel therapeutic approach for patients with interstitial cystitis\/ bladder pain syndrome (IC\/BPS). This systematic review and meta-analysis aim to evaluate the efficacy of PRP in alleviating pain and other related symptoms and outcomes in women.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This systematic review and meta-analysis followed PRISMA guidelines and the PICO framework. A comprehensive search was conducted in multiple databases. Risk of bias was assessed using the Cochrane Review Manager (RevMan), and quality of evidence was evaluated using the Modified Oxford Centre for Evidence-Based Medicine tool. All included studies were quasi-experimental, uncontrolled, and non-randomized, resulting in a low overall level of evidence\n                      <jats:bold>.<\/jats:bold>\n                      A pre\u2013post meta-analysis was performed assessing outcomes such as Global Response Assessment (GRA), pain (VAS), symptom scores (ICSI, ICPI, OSS), urinary frequency, nocturia, and urodynamic parameters. Standardized mean differences were calculated using a random-effects model, and heterogeneity was assessed using Cochran\u2019s Q test and the I\n                      <jats:sup>2<\/jats:sup>\n                      statistic.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The meta-analysis revealed a potential treatment effect, with a mean success rate (GRA\u2009\u2265\u20092) of 48%. Given that all the results derive from uncontrolled and non-randomized studies, they should therefore be interpreted with caution. Statistically significant improvements were observed in pain scores, urinary frequency, nocturia, and bladder function, including increases in Qmax and voided volume.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Intravesical PRP injection may represent a promising therapeutic option for refractory IC\/BPS, showing trends toward improvement in pain, nocturia, frequency, and bladder capacity. However, as current evidence is derived exclusively from uncontrolled and non-randomized studies, its efficacy remains uncertain and the findings should be interpreted with caution. Nonetheless, higher-quality randomized controlled trials are required to confirm its efficacy and better define its role in clinical practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00192-026-06515-9","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T15:54:53Z","timestamp":1775490893000},"page":"1515-1522","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Intravesical Platelet-Rich Plasma Injection for Refractory Interstitial Cystitis\/Painful Bladder Syndrome: A Systematic Review and Meta-analysis"],"prefix":"10.1007","volume":"37","author":[{"given":"Gabriel Chahade Sibanto","family":"Sim\u00f5es","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caio","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas Mira","family":"Gon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e1ssio Lu\u00eds Zanettini","family":"Riccetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8048-3871","authenticated-orcid":false,"given":"Gabriel Chahade Sibanto","family":"Sim\u00f5es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"issue":"5","key":"6515_CR1","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.juro.2015.01.086","volume":"193","author":"PM Hanno","year":"2015","unstructured":"Hanno PM, Erickson D, Moldwin R, Faraday MM. Diagnosis and treatment of interstitial cystitis\/bladder pain syndrome: AUA guideline amendment. J Urol. 2015;193(5):1545\u201353.","journal-title":"J Urol"},{"issue":"2B","key":"6515_CR2","doi-asserted-by":"publisher","first-page":"E136","DOI":"10.1111\/j.1464-410X.2010.09911.x","volume":"108","author":"JH Shie","year":"2011","unstructured":"Shie JH, Kuo HC. Higher levels of cell apoptosis and abnormal E-cadherin expression in the urothelium are associated with inflammation in patients with interstitial cystitis\/bladder pain syndrome. BJU Int. 2011;108(2B):E136-41.","journal-title":"BJU Int"},{"issue":"6","key":"6515_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198816","volume":"13","author":"JF Jhang","year":"2018","unstructured":"Jhang JF, Ho HC, Jiang YH, Lee CL, Hsu YH, Kuo HC. Electron microscopic characteristics of interstitial cystitis\/bladder pain syndrome and their association with clinical condition. PLoS ONE. 2018;13(6):e0198816. https:\/\/doi.org\/10.1371\/journal.pone.0198816.","journal-title":"PLoS ONE"},{"issue":"12","key":"6515_CR4","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1016\/j.cellsig.2008.06.004","volume":"20","author":"S Keay","year":"2008","unstructured":"Keay S. Cell signaling in interstitial cystitis\/bladder pain syndrome. Cell Signal. 2008;20(12):2174\u20139.","journal-title":"Cell Signal"},{"issue":"6","key":"6515_CR5","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1080\/09537104.2018.1430357","volume":"29","author":"J Etulain","year":"2018","unstructured":"Etulain J. Platelets in wound healing and regenerative medicine. Platelets. 2018;29(6):556\u201368.","journal-title":"Platelets"},{"issue":"5","key":"6515_CR6","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3109\/09537104.2016.1143922","volume":"27","author":"F Mussano","year":"2016","unstructured":"Mussano F, Genova T, Munaron L, Petrillo S, Erovigni F, Carossa S. Cytokine, chemokine, and growth factor profile of platelet-rich plasma. Platelets. 2016;27(5):467\u201371.","journal-title":"Platelets"},{"issue":"2","key":"6515_CR7","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s12035-013-8494-7","volume":"48","author":"DP Kuffler","year":"2013","unstructured":"Kuffler DP. Platelet-rich plasma and the elimination of neuropathic pain. Mol Neurobiol. 2013;48(2):315\u201332.","journal-title":"Mol Neurobiol"},{"issue":"2","key":"6515_CR8","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/nau.23898","volume":"38","author":"JF Jhang","year":"2019","unstructured":"Jhang JF, Lin TY, Kuo HC. Intravesical injections of platelet-rich plasma are effective and safe in the treatment of interstitial cystitis refractory to conventional treatment: a prospective clinical trial. Neurourol Urodyn. 2019;38(2):703\u20139.","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"6515_CR9","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/nau.23284","volume":"37","author":"\u00d6 G\u00fclp\u0131nar","year":"2018","unstructured":"G\u00fclp\u0131nar \u00d6, Esen B, Kay\u0131\u015f A, G\u00f6k\u00e7e M\u0130, S\u00fcer E. Clinical comparison of intravesical hyaluronic acid and chondroitin sulfate therapies in the treatment of bladder pain syndrome\/interstitial cystitis. Neurourol Urodyn. 2018;37(1):257\u201362.","journal-title":"Neurourol Urodyn"},{"key":"6515_CR10","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"issue":"2","key":"6515_CR11","first-page":"O42","volume":"11","author":"JF Jhang","year":"2017","unstructured":"Jhang JF, Wu SY, Lin TY, Kuo HC. Repeated intravesical injections of platelet-rich plasma are effective in the treatment of interstitial cystitis: a case-control pilot study. LUTS: Lower Urinary Tract Symptoms. 2017;11(2):O42\u20137.","journal-title":"LUTS: Lower Urinary Tract Symptoms"},{"key":"6515_CR12","volume":"13","author":"YH Jiang","year":"2022","unstructured":"Jiang YH, Jhang JF, Lin TY, Ho HC, Hsu YH, Kuo HC. Therapeutic efficacy of intravesical platelet-rich plasma injections for interstitial cystitis\/bladder pain syndrome: a comparative study of different injection numbers, additives, and concentrations. Front Pharmacol. 2022;13:871147.","journal-title":"Front Pharmacol"},{"issue":"5","key":"6515_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10051182","volume":"10","author":"YK Lee","year":"2022","unstructured":"Lee YK, Jiang YH, Jhang JF, Ho HC, Kuo HC. Changes in the ultrastructure of the bladder urothelium in patients with interstitial cystitis after intravesical injections of platelet-rich plasma. Biomedicines. 2022;10(5):1102.","journal-title":"Biomedicines"},{"issue":"Suppl 1","key":"6515_CR14","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.5213\/inj.2142100.050","volume":"26","author":"JF Jhang","year":"2022","unstructured":"Jhang JF, Jiang YH, Hsu YH, Ho HC, Birder LA, Lin TY, et al. Improved urothelial cell proliferation, cytoskeleton and barrier function protein expression in patients with interstitial cystitis\/bladder pain syndrome after intravesical platelet-rich plasma injection. Int Neurourol J. 2022;26(Suppl 1):S57-67.","journal-title":"Int Neurourol J"},{"issue":"2","key":"6515_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/toxins15020121","volume":"15","author":"JF Jhang","year":"2023","unstructured":"Jhang JF, Yu WR, Kuo HC. Comparison of the clinical efficacy and adverse events between intravesical injections of platelet-rich plasma and botulinum toxin A for the treatment of interstitial cystitis refractory to conventional treatment. Toxins. 2023;15(2):168.","journal-title":"Toxins"},{"issue":"5","key":"6515_CR16","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.arthro.2017.11.035","volume":"34","author":"ML Louis","year":"2018","unstructured":"Louis ML, Magalon J, Jouve E, Bornet CE, Mattei JC, Chagnaud C, et al. Growth factor levels determine efficacy of platelet-rich plasma injection in knee osteoarthritis: a randomized double-blind noninferiority trial compared with viscosupplementation. Arthroscopy. 2018;34(5):1530-40.e2.","journal-title":"Arthroscopy"},{"issue":"1","key":"6515_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-19419-6","volume":"8","author":"J Etulain","year":"2018","unstructured":"Etulain J, Mena HA, Meiss RP, Frechtel G, Gutt S, Negrotto S, et al. An optimized protocol for platelet-rich plasma preparation to improve its angiogenic and regenerative properties. Sci Rep. 2018;8(1):1513.","journal-title":"Sci Rep"},{"issue":"2","key":"6515_CR18","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00192-017-3355-y","volume":"29","author":"LE Olson","year":"2018","unstructured":"Olson LE, Dyer JE, Haq A, Ockrim J, Greenwell TJ. A systematic review of the literature on cystodistension in bladder pain syndrome. Int Urogynecol J. 2018;29(2):251\u20137.","journal-title":"Int Urogynecol J"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-026-06515-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00192-026-06515-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-026-06515-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T12:05:19Z","timestamp":1782475519000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00192-026-06515-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["6515"],"URL":"https:\/\/doi.org\/10.1007\/s00192-026-06515-9","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,6]]},"assertion":[{"value":"16 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was submitted to the Research Ethics Committee, which granted a waiver of approval for this research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Committee"}},{"value":"This study has not been previously presented at any meeting or congress.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Prior Presentation"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}